Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services 2023-01-18 19:00
Docquity delivers 10% market share growth for Philippine-based pharmaceutical client in just one year 2023-01-18 10:00
Boehringer Ingelheim Malaysia Honored As Top Employer For The Fifth Consecutive Year 2023-01-18 09:00
Boehringer Ingelheim Vietnam Honored As Top Employer For The Fourth Consecutive Year 2023-01-18 09:00
Telix Reports Fourth Quarter 2022 Financial Results 2023-01-18 08:50
Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer 2023-01-18 08:00
Everest Medicines Announces Top-line Data from Phase I Study of EVER206 on Healthy Subjects in China 2023-01-18 07:30
Abbisko Therapeutics Obtains Approval from The China NMPA to Conduct a Phase II Clinical Study of Pimicotinib (ABSK021） in cGVHD 2023-01-18 07:00
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC 2023-01-17 19:42
Ascletis Announces Entering into a Supply Agreement of Ritonavir Tablets with Simcere 2023-01-17 08:29
AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China 2023-01-17 08:00
JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA 2023-01-12 13:02
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 06:00
CGTN: TCM continues to play significant role in treating COVID-19 2023-01-11 23:09
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval 2023-01-11 09:00
Bio4t2 announces first patient infused with CAR-T targeting solid tumors 2023-01-11 09:00
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-2) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes 2023-01-11 00:00
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer 2023-01-10 21:05
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors 2023-01-10 21:05
Renexxion Announces Opening of Investigational New Drug (IND) Application for Naronapride for the Treatment of Gastrointestinal Dysmotility in Cystic Fibrosis Patients 2023-01-10 21:00
1 47 48 49 50 51 229